About Boltzmann
Boltzmann is a company based in Bengaluru (India) founded in 2019 by Paritosh Prashar and Kolli Sarath. Boltzmann has raised $112.7 thousand across 4 funding rounds from investors including ML Elevate, Madala Vineeth and GSD Venture Studios. Boltzmann operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Bengaluru, India
- Founders Paritosh Prashar, Kolli Sarath
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Boltzmann Labs Private Limited
- Date of Incorporation 02 May, 2019
- Jurisdiction Kolluru, Andhra Pradesh, India
-
Annual Revenue
$6.05 K (USD)0as on Mar 31, 2022
-
Net Profit
-$28.51 K (USD)-350.26as on Mar 31, 2022
-
EBITDA
-$17.22 K (USD)-219.38as on Mar 31, 2022
-
Total Equity Funding
$112.7 K (USD)
in 4 rounds
-
Latest Funding Round
$200 K (USD), Grant
Sep 28, 2023
-
Investors
ML Elevate
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Boltzmann
Unlock access to complete
Unlock access to complete
Funding Insights of Boltzmann
Boltzmann has successfully raised a total of $112.7K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $200 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Boltzmann
Boltzmann has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include ML Elevate, Madala Vineeth and GSD Venture Studios.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Accelerator focused on early-stage machine learning startups
|
Locked | Locked | Locked | |
|
Startups are accelerated by a sector-agnostic VC-as-a-service firm.
|
Locked | Locked | Locked | |
|
MV
Madala Vineeth |
-
|
Locked | Locked | Locked |
Investor details for Boltzmann
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Boltzmann
Investment portfolio details for Boltzmann
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Boltzmann
Detailed financials for Boltzmann
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Boltzmann Comparisons
Peer comparison for Boltzmann
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Boltzmann
Boltzmann operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Boltzmann
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Boltzmann
Complete news archive for Boltzmann
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boltzmann
Boltzmann was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Boltzmann is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Kolli Sarath is the current CEO of Boltzmann. They have also founded this company.
Boltzmann is a funded company, having raised a total of $112.7K across 4 funding rounds to date.
Annual revenue of Boltzmann is $6.05K as on Mar 31, 2022.
Boltzmann was founded in 2019 in Bengaluru, India, as an AI-driven platform focused on drug discovery for cancer and autoimmune diseases. Small molecule design and discovery are handled by BoltChem, while synthesis planning is supported by ReBolt. Multi-omic analysis is enabled through BoltBio, protein engineering for peptides and antibodies by BoltPro, and clinical trial design with biosimulation for personalized medicine by ClinBolt. Operations center on biotechnology and pharmaceuticals.
Boltzmann's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Boltzmann has 3 investors. Key investors include ML Elevate, Madala Vineeth, and GSD Venture Studios.
The valuation of Boltzmann is $7.12M as of Sep 2022.